These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Suppression of immunity to influenza virus infection in the respiratory tract following sleep disturbance. Brown R; Pang G; Husband AJ; King MG Reg Immunol; 1989; 2(5):321-5. PubMed ID: 2562046 [TBL] [Abstract][Full Text] [Related]
24. Significance of long lasting persistence of influenza virus antigens at the portal of infection and in the spleen of mice. Dubrovina TYa ; Ivanova IA; Shidlovskaya NK; Polyak RYa Acta Virol; 1992 Oct; 36(5):450-8. PubMed ID: 1364021 [TBL] [Abstract][Full Text] [Related]
25. Passive serum antibody causes temporary recovery from influenza virus infection of the nose, trachea and lung of nude mice. Kris RM; Yetter RA; Cogliano R; Ramphal R; Small PA Immunology; 1988 Mar; 63(3):349-53. PubMed ID: 2832312 [TBL] [Abstract][Full Text] [Related]
26. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung. Duhaut SD; Dimmock NJ Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233 [TBL] [Abstract][Full Text] [Related]
27. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. Scherle PA; Palladino G; Gerhard W J Immunol; 1992 Jan; 148(1):212-7. PubMed ID: 1530795 [TBL] [Abstract][Full Text] [Related]
28. Mucosal immunity to influenza without IgA: an IgA knockout mouse model. Mbawuike IN; Pacheco S; Acuna CL; Switzer KC; Zhang Y; Harriman GR J Immunol; 1999 Mar; 162(5):2530-7. PubMed ID: 10072492 [TBL] [Abstract][Full Text] [Related]
29. Pathogenesis of and immunity to avian influenza A H5 viruses. Katz JM; Lu X; Frace AM; Morken T; Zaki SR; Tumpey TM Biomed Pharmacother; 2000 May; 54(4):178-87. PubMed ID: 10872716 [TBL] [Abstract][Full Text] [Related]
30. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination. Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020 [TBL] [Abstract][Full Text] [Related]
31. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain. Droebner K; Haasbach E; Fuchs C; Weinzierl AO; Stevanovic S; Büttner M; Planz O Vaccine; 2008 Dec; 26(52):6965-74. PubMed ID: 18848593 [TBL] [Abstract][Full Text] [Related]
32. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942 [TBL] [Abstract][Full Text] [Related]
33. Active and passive immunization against oral Candida albicans infection in a murine model. Farah CS; Ashman RB Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599 [TBL] [Abstract][Full Text] [Related]
34. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. Sandbulte MR; Jimenez GS; Boon AC; Smith LR; Treanor JJ; Webby RJ PLoS Med; 2007 Feb; 4(2):e59. PubMed ID: 17298168 [TBL] [Abstract][Full Text] [Related]
35. The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection. Dong L; Mori I; Hossain MJ; Kimura Y J Infect Dis; 2000 Aug; 182(2):391-6. PubMed ID: 10915067 [TBL] [Abstract][Full Text] [Related]
36. Local IL-4 expression in the lung reduces pulmonary influenza-virus-specific secondary cytotoxic T cell responses. Bot A; Holz A; Christen U; Wolfe T; Temann A; Flavell R; von Herrath M Virology; 2000 Mar; 269(1):66-77. PubMed ID: 10725199 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the anti-influenza activities of antibodies and immune system cells administered intranasally to syngeneic mice. Maiorova LP; Smorodintsev AA Acta Virol; 1982 Sep; 26(5):353-61. PubMed ID: 6128903 [TBL] [Abstract][Full Text] [Related]
38. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy. Genovesi EV; Pettey CL; Collins JJ Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407 [TBL] [Abstract][Full Text] [Related]
39. Influenza infection in the infant mouse. Reuman PD; Ayoub EM; Small PA Pediatr Res; 1983 May; 17(5):338-43. PubMed ID: 6856395 [TBL] [Abstract][Full Text] [Related]
40. Resistance of mice to reinfection after E-aminocaproic acid treatment of primary influenza virus infection. Lozitsky VP; Puzis LE; Polyak RYa Acta Virol; 1988 Mar; 32(2):117-22. PubMed ID: 2899958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]